Arthritis, Rheumatoid
367
18
26
250
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Published Results
115 trials with published results (31%)
Research Maturity
250 completed trials (68% of total)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
9.0%
33 terminated out of 367 trials
88.3%
+1.8% vs benchmark
25%
93 trials in Phase 3/4
46%
115 of 250 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 250 completed trials
Clinical Trials (367)
Bone Erosions in Rheumatoid Arthritis - Characterization Evaluated by Imaging and Histology
A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)
Fucoidan in the Treatment of Active Rheumatoid Arthritis
Application of the Personalized N-of-1 Trial Design in Patients With Rheumatoid Arthritis
INFINITY™ With ADAPTIS™ Technology Study
Anatomical Shoulder Domelock System Study
Multidisciplinary Approach for Treat To Target In Rheumatoid Arthritis
Evaluation of Medium Cross-linked Polyethylene With and Without Vitamin E for Total Knee Arthroplasty
A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
Methotrexate and Metformin in Rheumatoid Arthritis Patients
Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis
UK Infinity, Post-Market Clinical Follow-up Study
Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases
Design and Evaluation of an Individualized Biodrug Tapering Strategy Based on Biodrug Dosage: the MONITORA Study
Evaluation of the Intestinal Microbiota and Bacterial Translocation in Patients With Rheumatoid Arthritis
Developing a Screening Tool for Interstitial Lung Disease in People With Rheumatoid Arthritis Using Risk Factors
A Study to Evaluate the Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoid Arthritis
Study of LW402 Tablets in Moderate to Severe Rheumatoid Arthritis
R-2487 in Patients With Rheumatoid Arthritis
The Reboot Study: A Safety Study of Abdominal Vagus Nerve Stimulation for Moderate to Severe Drug Refractory Rheumatoid Arthritis